Description

Docosahexaenoic Acid CAS NO 6217-54-5 is a long-chain ω-3 polyunsaturated fatty acid (PUFA) of significant biological and commercial importance. It is a critical structural component of cell membranes, particularly in the brain and retina, and is a precursor to potent bioactive mediators. This high-purity ingredient is essential for manufacturers in the nutraceutical, pharmaceutical, and infant formula industries seeking to enhance the functional profile of their products. Its role in supporting cognitive, cardiovascular, and visual health drives demand across global health and wellness markets.

Application

• Dietary Supplements & Nutraceuticals: A primary ingredient in ω-3 softgels, capsules, and liquid formulations targeting brain, heart, and eye health.
• Pharmaceutical Intermediates: Used in the synthesis of specialized lipid-based drug formulations and active pharmaceutical ingredients (APIs).
• Infant Formula Fortification: A vital additive to mimic the nutritional profile of breast milk, supporting neurological and visual development in infants.
• Clinical Nutrition & Medical Foods: Incorporated into enteral and parenteral nutrition products for patients with specific metabolic or nutritional deficiencies.
• Functional Food & Beverage Enrichment: Used for fortifying foods like dairy products, spreads, and beverages with health-promoting ω-3s.
• Cosmetic & Personal Care: Employed in topical formulations for its anti-inflammatory and skin-barrier enhancing properties.
• Animal Feed & Aquaculture: An essential nutrient added to feed for pets, livestock, and farmed fish to improve health and product quality.
• Biochemical & Cell Culture Research: Serves as a key reagent in lipidomics research, membrane studies, and specialized cell culture media.

Basic Information

Product Name	Docosahexaenoic Acid
CAS No.	6217-54-5
Molecular Formula	C22H32O2
Molecular Weight	328.49 g/mol
Synonyms	DHA; Cervonic Acid; (4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoic Acid; all-cis-Docosa-4,7,10,13,16,19-hexaenoic Acid; 22:6(n-3); MorDHA; ω-3 Fatty Acid 22:6
EINECS	228-289-7

Quality Control

Our Docosahexaenoic Acid is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and GC for fatty acid profile, to ensure compliance with relevant standards such as USP, FCC, and pharmaceutical-grade specifications. Comprehensive Certificates of Analysis (COA) detailing identity, assay, and impurity profiles are provided to guarantee supply reliability and batch-to-batch consistency for our B2B partners.

Storage

Preserve in a tightly closed container, protected from light. Store under an inert atmosphere (e.g., nitrogen) at -20°C or below for long-term stability. For short-term use, store at 2-8°C. This product is easily oxidized and moisture-sensitive; avoid exposure to air, heat, and humidity. Keep container tightly sealed when not in use.

Specification

Item	Specification
Appearance	Clear, Colorless to Pale Yellow Oil
Identification (IR)	Conforms
Assay (DHA, HPLC)	≥ 95.0%
Peroxide Value	≤ 5.0 meq/kg
Anisidine Value	≤ 20.0
Heavy Metals (as Pb)	≤ 10 ppm
Residual Solvents (GC)	Meets USP/ICH guidelines
Microbiological Count	Meets Ph. Eur. specifications

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.